The essentials
Free
$0 forever
- Access to free newsletter content
- Commentary on deals, policy, care models, and tech
- Select interviews and analyses
- Invitations to select webinars
Second Opinion membership
Enter your email to start free. You can choose a paid plan next.
Already a member? Sign in to upgrade or manage your account.
Having trouble? Use Ghost’s signup form.
Second Opinion membership
We’ve sent your confirmation email. Upgrade now for full access, or continue free.
The essentials
$0 forever
Full access
$250/year$25/month
Full access to exclusive programming, content, and archives for one person
Build it with us
$500/year$50/month
For those who want to be part of building Second Opinion, not just reading it.
Checkout not working? Choose a plan in Ghost Portal. Already paid? Sign in to your account.
While the healthcare industry remains locked in a high-level debate over the theoretical potential of artificial intelligence, a select group of digital health leaders are quietly deploying autonomous software agents to run core business infrastructure. This session moves past the theoretical hype to examine where AI agents are driving
While the healthcare industry remains locked in a high-level debate over the theoretical potential of artificial intelligence, a select group of digital health leaders are quietly deploying autonomous software agents to run core business infrastructure. This session moves past the theoretical hype to examine where AI agents are driving measurable financial outcomes right now — and where they aren’t. Moderator Christina Farr connects with Nick Perry (Candid Health) and Robert Krayn (Talkiatry) to trace how autonomous AI agents explicitly untangled a multi-year billing crisis, accelerated cash cycles, and sustained enterprise growth near the billion-dollar valuation threshold.
Expect us to cover:
Is AI ready for real-world clinical care? Dr. Zak Kohane and Protege’s Engy Ziedan debate what it takes to safely trust AI in diagnosis and treatment, from benchmark performance and clinical evidence to whether we’re holding AI to a higher standard than humans.